Add like
Add dislike
Add to saved papers

Tubulointerstitial Nephritis With Uveitis (TINU): A Syndrome Rheumatologists Should Recognize: A Case Report and Review of the Literature.

Patients with uveitis such as the patient whose case is reported here are often referred to rheumatologists for investigation of possible underlying systemic diseases. This patient presented with decreased vision, photophobia, weight loss, and fevers and was found to have uveitis, elevated creatinine, and interstitial nephritis. This raised consideration of a variety of systemic diseases before she was determined to have the tubulointerstitial nephritis with uveitis (TINU) syndrome. The TINU syndrome, although known to some ophthalmologists and nephrologists, is still rather obscure. Uncommon but not rare with 133 cases in the literature, TINU syndrome should be one more diagnosis to be considered in patients with uveitis. The median age of onset is 15, but it ranges from 9 to 74. There is a 3:1 female preponderance. Response to corticosteroids, which are used in 80% of reported cases, is rapid. The prognosis for the renal disorder is excellent, although the uveitis often recurs or remains chronic.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app